South Dakota House Bill 1099
Session 2026
Reschedule the pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the Food and Drug Administration as a Schedule IV controlled substance.
Became Law
Signed by Governor on Mar 10, 2026
First Action
Jan 21, 2026
Latest Action
Mar 10, 2026
Origin Chamber
House
Type
Bill
Bill Number
1099
State
South Dakota
Session
2026
Motion Text
Do Pass
House Roll Call Votes
Yes
Excused
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Excused
Yes
Yes
Yes
Yes
Yes
Yes
Excused
Yes
Yes
Excused
Yes
Yes
Yes
Yes
Yes
Yes
Excused
Yes
Yes
Yes
Summary
Unavailable
Sort by most recent
03/10/2026
Office of the Governor
Signed by the Governor on 2026-03-10 H.J. 547
03/05/2026
Senate
Delivered to the Governor on 2026-03-05 H.J. 520
03/04/2026
Senate
Signed by the President S.J. 470
03/03/2026
Senate
Signed by the Speaker H.J. 492
03/02/2026
Senate
Senate Do Pass , Passed, YEAS 21, NAYS 12 S.J. 429
02/26/2026
Senate
Remove from Consent Calendar S.J. 412
02/25/2026
Senate
Certified uncontested, placed on consent , Passed, S.J. 21
02/25/2026
Senate
Health and Human Services Do Pass , Passed, YEAS 6, NAYS 0 S.J. 21
02/25/2026
Senate
Scheduled for hearing S.J. 1
02/10/2026
Senate
First read in Senate and referred to Senate Health and Human Services S.J. 234
02/09/2026
House
House of Representatives Do Pass , Passed, YEAS 58, NAYS 7 H.J. 265
02/05/2026
House
Health and Human Services Do Pass , Passed, YEAS 13, NAYS 0 H.J. 13
02/05/2026
House
Scheduled for hearing H.J. 1
01/21/2026
House
First read in House and referred to House Health and Human Services H.J. 104
Sources
Open States
Record Created
Jan 20, 2026 8:19:50 PM
Record Updated
Mar 10, 2026 11:10:40 PM